# Beijing Avistone Pharmaceuticals Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-avistone-pharmaceuticals-biotechnology-co

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.avistonebio.com
- Total disclosed funding: $341M
- Latest round: Series B (Dec 28, 2023)
- Investors on record: 7

## About

Founded in 2018 and based in Beijing, China, Beijing Avistone Pharmaceuticals Biotechnology Co. Ltd. operates as a clinical-stage biotechnology company. Dr. Hepeng Shi is the founder and CEO of the company as of 2021. In December 2023, Beijing Avistone Pharmaceuticals Biotechnology Co., Ltd. raised CNY 1 billion in series B funding co-led by new investors SDIC Fund Management and IDG Capital, with participation from returning investor Bain Capital. New investors Yanchuang Capital and Cathay Capital also participated in the round.

The company has focused on developing precision oncology therapies for more than a decade and has a large oncology pipeline with a focus on lung cancer treatments. A c-Met inhibitor is in late-stage clinical development for genetically defined populations of non-small cell lung cancer (NSCLC) and glioblastoma (GBM).

The company plans to use the funding received in December 2023 to support its development and clinical research as well as its expansion in the United States of America.

## Funding rounds

- Series B, Dec 28, 2023, $141M — Bain Capital, IDG Capital, Cathay Capital, Yanchuang Capital, SDIC Fund Management
- Series A, Dec 8, 2021, $200M — Bain Capital, Vivo Capital, Primavera Capital Group

## Investors

- Bain Capital (https://capitalatlas.ai/funds/bain-capital) — Series A, Series B
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series A
- Primavera Capital Group (https://capitalatlas.ai/funds/primavera-capital-group) — Series A
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series B
- Cathay Capital — Series B
- Yanchuang Capital (https://capitalatlas.ai/funds/yanchuang-capital) — Series B
- SDIC Fund Management (https://capitalatlas.ai/funds/sdic-fund-management) — Series B